Thus, our results reveal mechanistic insight into the vicious cycle of obesity and depression induced by neural‐specific WFS1 deficiency and propose a therapeutic approach to counteract obesity and depression with riluzole. Here, WFS1 is linked to obesity due to melanocortin 4 receptor deficiency.